Bvg India Limited IPO

01At a glance

What the company does: integrated facility management across soft, hard and specialised services, plus emergency medical and police response services and environmental services, for clients in industry, transport infrastructure, healthcare and education, government and others (DRHP p.19). The F&S report it cites calls it India's largest IFM provider (DRHP p.19).

Who pays it: companies, hospitals, airports, railways, universities and government bodies; healthcare and education were 24.54% of FY25 revenue, transport infrastructure 16.88% and industrial and consumer 14.95% (DRHP p.39). The largest client was 12.13% of FY25 revenue and the top ten 39.95% (DRHP p.46).

Why it is raising money: ₹2,500.00 million to repay borrowings, and the rest for general purposes (DRHP p.20).

How fast it has grown: revenue from ₹23,149 million in FY23 to ₹28,394 million in FY24 and ₹33,018 million in FY25, 19.43% a year (DRHP p.21, DRHP p.117).

The one thing to understand: a labour business whose brand now belongs to its promoter. Employee costs were 68.32% of total expenses in FY25, and on 26 September 2025 the company assigned the "BVG" trademark and logo to Aadiruchi Foods LLP, owned by the promoter, for ₹19.61 million, and took a perpetual, non-exclusive licence back for an annual fee (DRHP p.22, DRHP p.37).

02The business, in plain words

A facility-management company supplies staff and supervisors to run services at a client's sites and bills for the people and services deployed.

A hospital chain outsources housekeeping and maintenance → BVG deploys staff and supervisors at each hospital → it pays the workers → it bills the hospital and waits for payment.

Trade receivables were outstanding for 114 days in FY25, down from 152 in FY23 (DRHP p.117).

Earnings equation: Profit ≈ billed manpower and services × (billing rate − wages and statutory costs) − overheads − interest. EBITDA margin from continuing operations was 11.03% in FY25 (DRHP p.117).

03Where the money comes from

Source: DRHP p.39, DRHP p.46.

04The growth record

Source: DRHP p.21, DRHP p.117, DRHP p.389.

Our arithmetic: revenue compounded about 19.4% a year from FY23 to FY25 and profit after tax about 28.7% (DRHP p.21).

05What the growth is made of

Headcount and healthcare. Staff grew from over 68,800 to over 85,600 between FY23 and FY25, and healthcare and education revenue rose 72% (our arithmetic, DRHP p.39, DRHP p.117). EBITDA margin narrowed as revenue grew faster than EBITDA (DRHP p.117).

06Earnings quality

Collections improved: receivable days fell from 152 to 114 and operating cash flow rose to ₹2,179.99 million in FY25 (DRHP p.117, DRHP p.389). Profit from continuing operations was higher than total profit in each year, meaning discontinued operations reduced reported profit (DRHP p.21, DRHP p.117). The company and others have filed compounding applications over alleged non-compliance with Ind AS provisions, which are pending (DRHP p.39).

07The balance sheet

Source: DRHP p.21, DRHP p.117.

Contingent liabilities at March 2025 were ₹922.45 million, mostly ₹790.51 million of service tax claims for FY13 to FY18 under appeal; performance guarantees of ₹3,421.50 million are excluded (DRHP p.23). The promoter has given personal guarantees for company loans and has pledged shares for a personal loan (DRHP p.23).

Our arithmetic: net debt of ₹3,132.47 million at March 2025 was 0.9 times the FY25 EBITDA of ₹3,641.41 million (DRHP p.21, DRHP p.117).

08What the money is for

Source: DRHP p.20.

09Who is selling

Source: DRHP p.20. The last row is our arithmetic. Together they offer up to 28,548,007 shares; the split was not read for this study (DRHP p.19).

The cover's offer-for-sale table gives the split: Hanmantrao Gaikwad 3,130,725 shares, Strategic Investments FM (Mauritius) Alpha Limited 15,495,032, Strategic Investments FM (Mauritius) B Limited 3,545,366, Vaishali Gaikwad 3,419,162, Vikas Vyankat Nipane 875,472, Aarya Agro-Bio and Herbals Private Limited 750,000, Umesh Gautam Mane 666,130 and Swapnali Dattatraya Gaikwad 666,120 (DRHP p.1).

10Promoters

The promoter is Hanmantrao Gaikwad (DRHP p.19). Proceedings against the promoter include 5 criminal, 2 tax and 1 civil matter involving ₹72.29 million (DRHP p.22).

11Who already owns it

Source: DRHP p.20. The last row is our arithmetic. Convertible debentures and preference shares convert into 4,672,100 shares before the red herring prospectus (DRHP p.20).

12What changed just before the IPO

• Trademark: assigned to promoter-owned Aadiruchi Foods LLP on 26 September 2025, and licensed back (DRHP p.37).

• Headcount: past 85,600 in FY25 (DRHP p.117).

• Receivables: collection period down to 114 days (DRHP p.117).

• Incorporation: the company was incorporated as a public limited company in March 2002 (DRHP p.3).

• Share split: the face value was sub-divided from ₹10 to ₹2 with a record date of 20 January 2024 (DRHP p.323).

• Promoter remuneration: Hanmantrao Gaikwad was paid ₹29.86 million in FY25 (DRHP p.266).

13Capacity and expansion

Capacity is people: more than 85,600 staff at 2,218 active sites at March 2025 (DRHP p.19, DRHP p.117). The proceeds repay debt (DRHP p.20).

14Market size and industry structure

The F&S report cited in the offer document projects India's outsourced facility-management market to grow 14.0% a year from FY2025 to ₹936.5 billion by FY2030 (DRHP p.19). Those projections are F&S's, and newboard has not tested them.

15Competitive position

What the document claims, and what it rests on:

• Scale: the largest IFM provider in India, citing F&S (DRHP p.19).
• Breadth: facility management plus emergency and environmental services (DRHP p.19).

Against that: wage-cost pressure, labour-law exposure, government payment delays and tendering risk, and the loss of ownership of its own brand (DRHP p.22, DRHP p.23).

16Peers the company named

The document gives the listed peers' P/E range as 13.83 to 426.17, average 220.00 (DRHP p.114). The peer names were not read for this study.

No P/E is possible for the company until a price band is set.

17Risks, in plain words

• Wages. Two-thirds of costs are staff (DRHP p.22).
• Brand. The company no longer owns "BVG"; the licence can be terminated in some cases (DRHP p.37).
• Government clients. Payment delays and tender risk (DRHP p.23).
• Litigation. Many proceedings, including 89 regulatory actions (DRHP p.22).
• Pledged shares. The promoter has pledged shares (DRHP p.23).

18Litigation and regulatory matters

Source: DRHP p.22.

19Related-party transactions

The trademark assignment to Aadiruchi Foods LLP and the licence back are described in section 11 (DRHP p.37). The rest was not read in detail for this study.

20What the offer document does not say

In the sections read for this study, the document does not give:

• The annual licence fee for the "BVG" trademark, in the pages read.
• Why the trademark was assigned to the promoter's firm four days before filing, in the pages read.
• What the ₹5,461 million of claims against the company concern, in the pages read.
• What the discontinued operations were, in the pages read.
• The price band, lot size or issue dates, which is normal at DRHP stage.

21Five questions for management

1. Why was the "BVG" trademark sold to the promoter's firm for ₹19.61 million, and what is the annual fee?
2. What are the 89 regulatory actions and 68 tax matters against the company?
3. What business was discontinued, and what did it cost?
4. What is the promoter's pledged loan for, and how large is it?
5. How are wage increases passed on to clients?

1Sources and cited facts

This study was read from 1 document the company filed. The 59 figures it cites are listed under the document each came from, with the page and the sentence as printed.